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Identiﬁcation of peripheral neural circuits that
regulate heart rate using optogenetic and viral
vector strategies
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Heart rate is under the precise control of the autonomic nervous system. However, the wiring
of peripheral neural circuits that regulate heart rate is poorly understood. Here, we develop a
clearing-imaging-analysis pipeline to visualize innervation of intact hearts in 3D and
employed a multi-technique approach to map parasympathetic and sympathetic neural cir-
cuits that control heart rate in mice. We identify cholinergic neurons and noradrenergic
neurons in an intrinsic cardiac ganglion and the stellate ganglia, respectively, that project to
the sinoatrial node. We also report that the heart rate response to optogenetic versus
electrical stimulation of the vagus nerve displays different temporal characteristics and that
vagal afferents enhance parasympathetic and reduce sympathetic tone to the heart via
central mechanisms. Our ﬁndings provide new insights into neural regulation of heart rate,
and our methodology to study cardiac circuits can be readily used to interrogate neural
control of other visceral organs.
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S ituation-dependent changes in heart rate are essential forsurvival and are under the precise control of the autonomicnervous system (ANS)1. Heart rate reduction during sleep2
and elevation during exercise3 result from changes in para-
sympathetic and sympathetic tone. In fact, heart rate variability
has been utilized extensively as an index of ANS function4–6.
Although it is well known that the parasympathetic and sympa-
thetic nervous systems innervate the sinoatrial (SA) node7,8 and
regulate heart rate9–13, the wiring of these neural circuits in the
periphery is not well characterized. Anatomical and functional
maps of these fundamental cardiac circuits are needed to
understand physiology, characterize remodeling in disease (e.g.,
sick sinus syndrome14), and develop novel therapeutics. However,
these efforts have been hindered by a shortage of tools that target
the peripheral nervous system (PNS) with speciﬁcity and
precision.
Cardiac circuit anatomy has traditionally been studied using thin
sections15 and whole-mount preparations16. However, these
methods do not preserve the structure of intact circuits and only
provide 2D information. In contrast, tissue clearing methods render
tissues optically transparent while preserving their molecular and
cellular architecture and can be combined with a variety of labeling
strategies to enable 3D visualization of intact circuits17,18. To trace
cardiac circuits, dyes and proteins have historically been used.
However, achieving cell type-speciﬁcity and/or sparse labeling
needed for singe-cell tracing and delineating circuit connectivity is
difﬁcult or not possible with these methods19. Additionally, many
peripheral neuronal populations such as intrinsic cardiac ganglia are
challenging to access surgically for tracer delivery. Adeno-associated
viruses (AAVs) can address these limitations since they can be used
to express genes of interest (e.g., ﬂuorescent proteins) in deﬁned cell
populations in wild-type and transgenic animals20–22. In addition,
intersectional strategies can be used to titrate gene expression to
achieve sparse labeling21. AAVs can also be delivered systemically
to target difﬁcult-to-reach populations20–22.
Functional mapping of cardiac circuits has relied on electrical
or pharmacological manipulation of the ANS with simultaneous
physiological measurements23,24. However, each of these methods
has disadvantages. Electrical techniques lack spatial precision and
speciﬁcity. Autonomic nerves such as the vagus contain motor
and sensory ﬁbers25, and electrical stimulation typically activates
both ﬁber types26,27 as well as surrounding tissues28. Pharma-
cological techniques exhibit improved selectivity but lack
temporal resolution. In contrast, optogenetics, which uses
light-sensitive ion channels (e.g., channelrhodopsin-2 (ChR2),
halorhodopsin), enables precise spatiotemporal control of deﬁned
cell populations.
Here, we develop a clearing-imaging-analysis pipeline to
visualize innervation of whole hearts in 3D and employ a multi-
technique approach, which includes AAV-based sparse labeling
and tracing, retrograde neuronal tracing with cholera toxin sub-
unit B (CTB), and optogenetics with simultaneous physiological
measurements, to map peripheral parasympathetic and sympa-
thetic neural circuits that regulate heart rate in mice.
Results
Tissue clearing and computational pipeline to assess cardiac
innervation. To characterize global innervation of the mouse
heart in 3D, we developed a clearing-imaging-analysis pipeline
(Fig. 1a). We stained whole hearts with an antibody against the
pan-neuronal marker protein gene product 9.5 (PGP9.5) and
rendered them optically transparent using an immunolabeling-
enabled three-Dimensional Imaging of Solvent-Cleared Organs
(iDISCO) protocol (Fig. 1b)29. We used confocal microscopy to
image large tissue volumes (Fig. 1c and Supplementary Movie 1)
and both confocal and lightsheet microscopy to image entire
hearts (Supplementary Movie 2)30,31. We observed cardiac
ganglia surrounding the pulmonary veins and a dense network of
nerve ﬁbers coursing through the atrial and ventricular
myocardium (Fig. 1c). In contrast to whole-mount stained hearts,
innervation was seen throughout the entire thickness of the
myocardium in iDISCO-cleared hearts, with large-diameter nerve
ﬁber bundles located near the epicardium and smaller ﬁber
bundles in the mid-myocardium and endocardium (Fig. 1c,
Supplementary Fig. 1, and Supplementary Movie 3). To analyze
these data, we created a semiautomated computational pipeline to
detect nerve ﬁbers over large tiled volumes and to measure
microanatomical features of ﬁbers such as diameter and orien-
tation (Fig. 1d and e). Large-diameter nerve ﬁber bundles typi-
cally entered near the base of the dorsal heart. These bundles
coursed perpendicular to the atrioventricular (AV) groove and
branched into smaller ﬁber bundles as they progressed towards
the apex. These data from healthy hearts will be important for
future characterization of neural remodeling in cardiovascular
diseases such as myocardial infarction (MI) in which innervation
patterns are disrupted and nerve sprouting occurs32,33.
While the iDISCO protocol was speciﬁcally developed for
immunostaining applications, other clearing techniques such as
the PAssive Clarity Technique (PACT) are better suited for
visualizing endogenous ﬂuorescence in large tissue volumes or
whole organs30,34. We demonstrate that PACT preserves the
ﬂuorescence of virally labeled cholinergic and endogenously labeled
noradrenergic neurons and nerve ﬁbers in the heart (Supplementary
Fig. 2 and Supplementary Movies 4–6). Therefore, the application
should dictate the choice of clearing technique.
AAV-based labeling and tracing of cholinergic neurons on the
heart. After visualizing global cardiac innervation, we assessed
whether we could identify a subset of cholinergic neurons that form
an anatomical circuit with the SA node to potentially regulate heart
rate. We used an AAV-based system to trace ﬁbers, presumably
from cholinergic neurons in intrinsic cardiac ganglia. Multicolor
labeling strategies allow individual cells to be distinguished from
one another (Fig. 2a) and sparse labeling reduces the fraction of
labeled cells to allow individual ﬁbers to be visualized (Fig. 2b)21. To
demonstrate this, we systemically co-administered Cre-dependent
vectors expressing ﬂuorescent proteins (XFPs) from the
tetracycline-responsive element (TRE)-containing promoter at a
high dose and the tetracycline transactivator (tTA) from the human
synapsin I promoter (hSyn1) at a lower dose in ChAT-IRES-Cre
transgenic mice (Fig. 2b)21. Compared to dense multicolor labeling
(Fig. 2a), sparse multicolor labeling resulted in a labeling density in
intrinsic cardiac ganglia that was lower and that would more easily
allow for tracing (Fig. 2b)21. To trace cholinergic ﬁber, we utilized
sparse single-color labeling with tdTomato. Three weeks after viral
delivery, hearts were collected and stained with an antibody for
hyperpolarization-activated cyclic nucleotide-gated potassium
channel 4 (HCN4). HCN4 staining along with anatomical land-
marks were used to identify the SA node, the AV node, and the
conduction system35,36. We observed cholinergic ﬁbers, presumably
from cardiac ganglia, coursing along the SA node, AV node, and
ventricles (Fig. 2c), identifying cholinergic neurons that are poten-
tially involved in chronotropic, dromotropic, and ventricular con-
trol, respectively.
Optogenetic stimulation of cholinergic neurons in the inferior
pulmonary vein-ganglionated plexus. Next, to functionally assess
whether cholinergic neurons in the inferior pulmonary vein-
ganglionated plexus (IPV-GP) regulate heart rate and AV con-
duction, we used an optogenetic approach. We expressed ChR2 in
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cholinergic neurons by crossing transgenic ChAT-IRES-Cre mice
with reporter mice containing a Cre-dependent ChR2-enhanced
yellow ﬂuorescent protein allele (ChR2-eYFP; offspring from this
cross are subsequently referred to as ChAT-ChR2-eYFP mice).
ChR2-eYFP expression in intrinsic cardiac neurons was conﬁrmed
by staining hearts for GFP (to amplify ChR2-eYFP detection) and
PGP9.5 (Fig. 3a). All GFP+ neurons were PGP9.5+ (100.0 ± 0.0%)
and the majority of PGP9.5+ neurons were GFP+ (96.4 ± 1.2%)
(Fig. 3b). GFP staining was also present in PGP9.5+ nerve ﬁbers in
the atria and ventricles (Fig. 3a). These data are consistent with
previous studies reporting that the majority of intrinsic cardiac
neurons are cholinergic37 and that the ventricles as well as atria
receive cholinergic innervation37–39.
After verifying ChR2 expression, we next assessed whether
selective stimulation of cholinergic neurons in the IPV-GP
modulated heart rate and AV nodal conduction using optoge-
netics in ex vivo Langendorff-perfused hearts. A blue laser-
coupled optical ﬁber was positioned for focal illumination of the
IPV-GP while cardiac electrical activity was simultaneously
recorded (Fig. 3c, d). Optogenetic stimulation resulted in a
decrease in heart rate that was dependent on light pulse power,
frequency, and pulse width (Fig. 3e–g and Supplementary Table 1)
but did not change the AV interval (35.7 ± 1.2 ms before
stimulation versus 35.9 ± 1.0 ms during stimulation) (Fig. 3h).
The lack of change in AV nodal conduction suggests that ﬁbers
from this ganglion may pass through the AV node without
synapsing. In addition, stimulation prolonged the P wave
duration (9.3 ± 1.0 ms before stimulation versus 12.3 ± 2.4 ms
during stimulation) and caused P wave fractionation (Fig. 3i, j). P
wave fractionation has been reported in humans following
administration of adenosine40, which mimics the effects of
acetylcholine released from cholinergic nerve terminals41,42.
During stimulations at higher frequencies, we occasionally
observed ectopic atrial rhythms (n= 3/6 mice) and even asystole
(n= 1/6 mice) (Fig. 3d), demonstrating the profound effect of the
IPV-GP on the SA node and atrial function. The response to
stimulation was abolished by administration of the muscarinic
receptor antagonist atropine (−33.5 ± 11.0% with stimulation
before atropine versus −0.3 ± 0.2% with stimulation after
atropine) (Fig. 3k and Supplementary Table 1), indicating that
the bradycardic response was indeed mediated by selective
stimulation of cholinergic neurons.
Since ChR2 is expressed in both preganglionic cholinergic
inputs to and postganglionic cholinergic neurons in the IPV-GP
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Fig. 1 Tissue clearing and computational pipeline to assess cardiac innervation. a Schematic of the clearing-imaging-analysis pipeline for assessing cardiac
innervation. b A whole heart (top) was rendered transparent (bottom) using the iDISCO protocol. c 3D confocal projections of the ventral (1500 µm z-
stack) and dorsal side of a cleared heart (1200 µm z-stack) with PGP9.5 staining (gray). Inset 1 shows a maximum intensity projection (MIP) confocal
image of a cardiac ganglion. Inset 2 shows 785 µm-thick 3D projections of the entire left ventricular wall. d, e A semiautomated computational pipeline was
used to detect nerve ﬁbers in the dorsal heart image from (c) and derive their diameter (d) and orientation (e). Insets show higher magniﬁcation images.
Scale bars are 2mm (b), 1 mm (c (top), d (left), e (left)), and 100 µm (c (bottom), d (right), e (right))
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in ChAT-ChR2-eYFP mice, we assessed whether we could
stimulate only postganglionic cholinergic neurons in the IPV-
GP using optogenetics and still modulate heart rate. We ﬁrst
evaluated whether we could preferentially deliver transgenes to
peripheral cholinergic neurons in intrinsic cardiac ganglia rather
than central cholinergic neurons in the medulla using systemic
AAVs. We used AAV-PHP.S, a capsid variant that more
efﬁciently transduces the PNS and many visceral organs including
the heart, as compared to AAV921. We packaged a Cre-
dependent genome that expresses eYFP from the ubiquitous
CAG promoter into AAV-PHP.S and systemically administered
the virus to ChAT-IRES-Cre transgenic mice. Three weeks later,
we evaluated eYFP expression in the medulla, vagus nerve, and
cardiac ganglia with GFP staining. Central cholinergic neurons in
the dorsal motor nucleus of the vagus nerve (DMV) (1.5 ± 0.9%
expressed GFP) and ﬁbers in the vagus nerve were weakly
transduced (Supplementary Fig. 3a–c). In contrast, we observed
robust transduction of peripheral cholinergic neurons in cardiac
ganglia (91.0 ± 1.5%) (Supplementary Fig. 3d and e), likely due to
the strong tropism AAV-PHP.S displays for the PNS over the
CNS. Further, GFP expression was highly speciﬁc for ChAT+
neurons in cardiac ganglia (100.0 ± 0.0%) (Supplementary Fig. 3e).
For functional studies, we packaged a Cre-dependent genome that
expresses ChR2-eYFP from the ubiquitous CAG promoter in
AAV-PHP.S, systemically administered the virus to ChAT-IRES-
Cre transgenic mice, and evaluated expression 5 weeks later. In
Langendorff-perfused hearts, we were able to optogenetically
stimulate postganglionic cholinergic neurons in the IPV-GP and
decrease heart rate (Supplementary Fig. 4). Taken together, our
anatomical and functional data establish an IPV-GP-SA node
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dependent vectors expressing either mRuby2, mNeonGreen, or mTurquoise2 from the ubiquitous CAG promoter (ssAAV-PHP.S:CAG-DIO-XFPs) (1 × 1012
vector genomes (vg) each; 3 × 1012 vg total). A MIP image of a densely labeled cardiac ganglion (bottom left). Inset shows a higher magniﬁcation image
(bottom right). b Schematic of the two-component expression system for cell type-speciﬁc, sparse multicolor labeling (top). Expression of XFPs is
dependent on cotransduction of an inducer in Cre-expressing cells. The dose of the inducer vector can be titrated to control extent of XFP labeling. To
sparsely label cholinergic neurons in cardiac ganglia, ChAT-IRES-Cre mice were systemically co-administered 3 Cre-dependent vectors expressing XFPs
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co-administering ssAAV-PHP.S:TRE-DIO-tdTomato at a high dose (1 × 1012 vg) and ssAAV-PHP.S:ihSyn1-DIO-tTA at a lower dose (1 × 1010 vg). Cartoon of
the dorsal heart depicting the orientation of images (left). A MIP image of the dorsal atrium with native tdTomato ﬂuorescence (red) and HCN4 staining
(green) (middle). Fibers were traced with neuTube and overlaid on a grayscale MIP image (right). Orange ﬁbers coursed along the right atrium (RA)
including the sinoatrial (SA) and atrioventricular (AV) nodes and blue ﬁbers along the ventricles. Scale bars are 50 µm (a, b) and 200 µm (c). All images
were acquired on tissue collected 3 weeks after intravenous injection. IPV-GP inferior pulmonary vein-ganglionated plexus, IVC inferior vena cava, LA left
atrium, LV left ventricle, PV pulmonary vein, RV right ventricle, SVC superior vena cava
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09770-1
4 NATURE COMMUNICATIONS |         (2019) 10:1944 | https://doi.org/10.1038/s41467-019-09770-1 | www.nature.com/naturecommunications
circuit involved in heart rate regulation (Fig. 3l). Furthermore, the
engineered AAV, AAV-PHP.S21, can be a powerful tool to dissect
out the roles of peripheral versus central circuits on organ
control.
Optogenetic versus electrical stimulation of the vagus nerve.
Electrical vagus nerve stimulation (VNS) has been used in
numerous preclinical and clinical studies for the treatment of
cardiovascular diseases43 and other conditions (e.g., rheumatoid
arthritis44). However, the relative contributions of vagal efferent
and afferent ﬁbers on cardiac function are not well understood
because conventional techniques do not allow for ﬁber type-
speciﬁc stimulation. To address this limitation, we examined
whether we could selectively stimulate efferent ﬁbers in the vagus
nerve using optogenetics. We also assessed whether there was a
difference between optogenetic and electrical VNS on heart rate
(Fig. 4a), as a previous study showed that electrical stimulation of
motor nerves results in a non-orderly, non-physiological
recruitment of ﬁbers, with larger ﬁbers activated ﬁrst45. The
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vagus and other autonomic nerves contain both motor and sen-
sory ﬁbers that vary in diameter and myelination28 and non-
electrical techniques such as optogenetics are needed to study
their physiological role.
To conﬁrm that ChR2-eYFP expression was limited to vagal
efferents in ChAT-ChR2-eYFP mice, we stained for GFP and
PGP9.5 in the nodose/jugular ganglion complex, which contains
the cell bodies of vagal sensory neurons, and the cervical vagus
Fig. 3 Ex vivo optogenetic stimulation of cholinergic neurons in the IPV-GP. a A 3D projection (1200 µm z-stack) of the dorsal side of a heart from a ChAT-
ChR2-eYFP mouse whole-mount stained with PGP9.5 (red) and GFP (green). Insets 1 and 2 show MIP images of a cardiac ganglion and the ventricle,
respectively. Blue dashed boxes indicate location of higher magniﬁcation images in blue boxes. b Percentage of cardiac ganglion neurons expressing GFP
and PGP9.5 over those expressing GFP or PGP9.5. c Langendorff-perfused hearts were used for optogenetic stimulation of cholinergic neurons in a cardiac
ganglion. A blue laser-coupled optical ﬁber was positioned for focal illumination of the IPV-GP (circle). A surface electrocardiogram (ECG) was recorded
with bath electrodes and intracardiac electrograms with an electrophysiology (EP) catheter. d Representative ECGs during stimulation (blue shading) at
10 Hz, 10ms, and 221 mW (top) and 20 Hz, 10 ms, and 221 mW (bottom). Insets show the ECGs before and during stimulation. e–g Dose response
curves summarizing the effects of altering light pulse power (e), frequency (f), and pulse width (g) on heart rate. h Summary of the AV interval before and
during stimulation at 10 Hz and 10ms (t4= 0.1656, P= 0.8765). i Representative ECG during stimulation (blue shading) at 10 Hz, 10 ms, and 221 mW.
Insets show a single beat before and during stimulation, with gray boxes showing a higher magniﬁcation of the P wave. j The P wave duration before versus
during stimulation (t5= 2.920, *P= 0.0330). k Summary of the heart rate response to stimulation before versus after atropine administration (t4= 2.993,
*P= 0.0402). l Cartoon of the dorsal heart depicting the IPV-GP-SA node circuit. n= 6 mice (b, e–g, j) and 5 mice (h, k); mean ± s.e.m.; paired, two-tailed
t-test. Scale bars are 1 mm (a (left), c) and 100 µm (a (right))
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Frequency response curves summarizing the effects of optogenetic versus electrical RVNS on heart rate in the intact state. e, f Frequency response curves
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nerve (Fig. 4b). eYFP was not detected in PGP9.5+ cell bodies in
the nodose/jugular ganglion complex and was only present in a
subset of PGP9.5+ vagal ﬁbers (n= 5 mice). After verifying
expression, we next performed functional studies in anesthetized
mice in which we positioned a laser-coupled optical ﬁber for focal
illumination above and a hook electrode underneath the right
vagus nerve. In this context, optogenetic VNS activates only
efferent ﬁbers (GFP+), whereas electrical VNS presumably
activates subsets of efferent and afferent ﬁbers (PGP9.5+) in
the vagus nerve (Fig. 4b). With both vagi intact, optogenetic and
electrical right VNS resulted in a similar decrease in heart rate
(Fig. 4c and d); however, the slopes of the responses were
dramatically different (n= 6/8 mice) (Fig. 4c), likely due to
differential ﬁber recruitment45. The heart rate response to
optogenetic versus electrical stimulation of the caudal end of
the right vagus nerve was also similar following either right or
bilateral vagotomy (Fig. 4e, f and Supplementary Table 2). In
contrast, optogenetic stimulation of the cranial end of the right
vagus nerve following either right or bilateral vagotomy did not
affect heart rate, whereas electrical stimulation surprisingly
resulted in a decrease in heart rate at 10 Hz (−6.5 ± 1.8% versus
−0.1 ± 0.1% following right vagotomy for electrical versus
optogenetic stimulation) and 20 Hz (−9.9 ± 1.8% versus −0.1 ±
0.1% following right vagotomy and −3.2 ± 0.4% versus −0.2 ±
0.1% following bilateral vagotomy for electrical versus optoge-
netic stimulation) (Fig. 4g, h and Supplementary Table 2). The
decrease in heart rate to electrical stimulation of the cranial end of
the right vagus nerve following right vagotomy was also greater
than that following bilateral vagotomy at 20 Hz (t4= 3.123, P=
0.0354, paired, two-tailed t-test) (Fig. 4g, h, red line and
Supplementary Table 2), suggesting that the response following
ipsilateral vagotomy was in part due to a vagal afferent-mediated
increase in parasympathetic efferent outﬂow through the intact
contralateral vagus nerve. Furthermore, the decrease in heart rate
to electrical stimulation of the cranial end of the right vagus nerve
following bilateral vagotomy (Fig. 4h, red line and Supplementary
Table 2) indicates that vagal-afferents mediate a decrease in
sympathetic efferent outﬂow, since both vagi were transected. In
addition, there was an increased latency to peak heart rate
response with electrical stimulation of the cranial end of the right
vagus nerve following bilateral vagotomy compared to that of the
intact right vagus nerve (8.7 ± 0.4 ms versus 3.9 ± 0.5 ms) (Fig. 4i),
which further supports that vagal afferents cause withdrawal of
sympathetic tone46. Taken together, our data suggest that
optogenetic stimulation selectively activates vagal efferents in
ChAT-ChR2-eYFP mice and that vagal afferents act centrally to
(1) increase parasympathetic efferent outﬂow and (2) decrease
sympathetic efferent outﬂow to the heart.
Location and optogenetic stimulation of cardiac-projecting
noradrenergic neurons in the stellate ganglia. The sympathetic
nervous system, along with the parasympathetic nervous system,
precisely regulates heart rate in normal physiology. To anato-
mically and functionally dissect noradrenergic neurons that form
a circuit with the SA node, we used a retrograde neuronal tracer
and an optogenetic approach. Noradrenergic nerve ﬁbers densely
innervate the heart as shown by staining for tyrosine hydroxylase
(TH), the rate-limiting enzyme in norepinephrine synthesis
(Fig. 5a). To identify the location of cardiac-projecting sympa-
thetic neurons, we injected the retrograde neuronal tracer CTB
conjugated to Alexa Fluor 488 into the heart (Fig. 5b). The
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majority of CTB+ neurons were located in the stellate ganglia of
the paravertebral chain, with fewer labeled neurons in the middle
cervical and second thoracic (T2) ganglia (Fig. 5c and Supple-
mentary Movie 7). On average, 236 ± 39 neurons were labeled in
the right and 261 ± 34 neurons labeled in the left stellate ganglion
(n= 5 mice). Heat maps of the right stellate ganglion (RSG) and
left stellate ganglion show that cardiac-projecting sympathetic
neurons are clustered in the craniomedial aspect (Fig. 5d) and
suggest that these ganglia may have a viscerotopic organization.
Next, we assessed whether we could selectively stimulate
noradrenergic neurons in the paravertebral chain using optoge-
netics and modulate heart rate (Fig. 6a). We expressed ChR2 in
noradrenergic neurons by crossing transgenic TH-IRES-Cre mice
with reporter mice containing a Cre-dependent ChR2-eYFP allele
(offspring from this cross are subsequently referred to as TH-
ChR2-eYFP mice). ChR2-eYFP expression in stellate ganglion
neurons was conﬁrmed by staining for GFP and TH (Fig. 6b). The
majority of GFP+ neurons were TH+ (98.7 ± 0.4%) and all TH+
neurons were GFP+ (100.0 ± 0.0%) (Fig. 6c). After verifying
expression, we performed functional studies in open-chest
anesthetized mice in which we positioned a laser-coupled optical
ﬁber for focal illumination above the craniomedial RSG or right
T2 ganglion (Fig. 6a). Optogenetic stimulation of the craniomedial
RSG resulted in a frequency- and pulse width-dependent increase
in heart rate (Fig. 6d–f and Supplementary Table 3). Although a
small number of cardiac-projecting neurons were located in the
T2 ganglion (Fig. 5c), there was no heart rate response to
stimulation of this ganglion and/or preganglionic sympathetic
ﬁbers coursing through this region (0.1 ± 0.1% with right T2
ganglion stimulation versus 9.5 ± 1.8% with RSG stimulation)
(Fig. 6g and Supplementary Table 3). The response to craniome-
dial RSG stimulation was abolished by administration of the β-
adrenergic receptor antagonist propranolol (5.6 ± 1.4% with
stimulation before propranolol versus 0.1 ± 0.1% with stimulation
after propranolol) (Fig. 6h and Supplementary Table 3), indicating
that the tachycardic response was indeed mediated by selective
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stimulation of noradrenergic neurons. Taken together, our
anatomical and functional data establish a craniomedial RSG-SA
node circuit involved in heart rate regulation (Fig. 6i).
Discussion
We developed a clearing-imaging-analysis pipeline to visualize
innervation of whole hearts and employed a multi-technique
approach to dissect fundamental parasympathetic and sympa-
thetic neural circuits involved in heart rate regulation. We report
several novel ﬁndings: (1) cholinergic neurons in the IPV-GP and
noradrenergic neurons in the craniomedial RSG project to the SA
node and modulate its function; (2) the evoked cardiac response
to optogenetic versus electrical stimulation of the vagus nerve
displays different temporal characteristics; and (3) vagal afferents
enhance parasympathetic and reduce sympathetic efferent out-
ﬂow to the heart via central mechanisms.
Despite advances in tissue clearing33,47 and imaging
techniques30,31, high-resolution, 3D datasets of global cardiac
innervation do not exist. We show, for the ﬁrst time, innervation
of entire cleared mouse hearts with cardiac ganglia located
around the pulmonary veins and a dense network of nerve ﬁbers
throughout the myocardium. To analyze these data, we developed
a semiautomated computational pipeline to detect nerve ﬁbers
and to measure microanatomical features such as diameter and
orientation. These analytical tools and resulting measurements
are needed to build a reference atlas of cardiac innervation and
for quantitative descriptions of innervation in healthy versus
diseased states such as MI. Following MI, innervation around the
infarct scar and of remote regions of the heart is altered32,33,48,
and this neural remodeling can modulate the arrhythmia sub-
strate49. Understanding changes in innervation post-MI can
provide new insights into arrhythmia mechanisms. Furthermore,
our clearing-imaging-analysis pipeline can be readily applied to
assess innervation of other visceral organs including endogen-
ously and virally labeled tissues.
It is well known that the parasympathetic and sympathetic
nervous systems are critical for heart rate regulation. The SA node
and conduction system are densely innervated7,8, and stimulation
of the vagus nerve9, stellate ganglia10, and noradrenergic
ﬁbers11,12 modulates heart rate. However, the precise wiring of
the underlying neural circuits has not been delineated. We used a
novel sparse AAV labeling system21 and an optogenetic approach
to anatomically and functionally characterize cholinergic neurons
that regulate heart rate. Although we were unable to directly
visualize synapses, we identiﬁed cholinergic ﬁbers, presumably
from cardiac ganglia, that coursed along the SA node, the AV
node, and the ventricles. Selective optogenetic stimulation of
cholinergic neurons in the IPV-GP modulated heart rate, con-
sistent with a recent study that stimulated cholinergic ﬁbers in the
right atrium also using optogenetics13. Previous studies showed
that electrical stimulation of pulmonary vein ganglia results in
biphasic heart rate responses (initial bradycardia followed by
tachycardia)23,24. However, since electrical stimulation is non-
speciﬁc, it is difﬁcult to interpret whether the biphasic response
was due to activation of a mixed population of neurons contained
in cardiac ganglia (i.e., parasympathetic, sympathetic, and sen-
sory)15 and/or pass through ﬁbers. Our ﬁndings demonstrate an
IPV-GP-SA node circuit and highlight the importance of using
techniques such as optogenetics, which confer cell type-speciﬁ-
city, to dissect cardiac neural circuity. Furthermore, electrical and
optogenetic techniques (using traditional transgenic and AAV-
based approaches for ChR2 delivery) stimulate both central
preganglionic inputs to and postganglionic neurons in cardiac
ganglia. Therefore, we used a novel engineered AAV, AAV-PHP.
S21, that has a strong tropism for the PNS to preferentially deliver
ChR2 to postganglionic cholinergic neurons on the heart rather
than preganglionic cholinergic neurons in the medulla. Future
studies of peripheral neural circuits should use AAV-PHP.S and
other engineered AAVs20,22 to dissect the role of central versus
peripheral neuronal populations on organ function.
To map noradrenergic neurons that regulate heart rate, we
used a retrograde neuronal tracer and optogenetic approach. A
previous study in canines using horseradish peroxidase showed
that sympathetic postganglionic neurons that innervate the heart
are primarily located in the middle cervical ganglia of the para-
vertebral chain50. However, we report, using CTB and conﬁrm
with optogenetic stimulation, that the stellate ganglia have a
viscerotopic organization with cardiac-projecting neurons clus-
tered in the craniomedial aspect, consistent with a study in cats51.
In addition to the heart, the stellate ganglia project to many other
thoracic structures, including the sweat glands in the forepaw52,
the lung and trachea53, the esophagus51, and brown fat54. Char-
acterizing stellate ganglia target innervation and cell-type speci-
ﬁcation is an area of ongoing investigation55,56 that is of interest
from a developmental, physiological, and therapeutic perspective.
Current understanding of the role of vagal efferent and afferent
ﬁbers on cardiac function is largely based on studies using elec-
trical stimulation, which is non-speciﬁc and results in non-
orderly, non-physiological recruitment of ﬁbers45. Electrical sti-
mulation of the vagus nerve typically activates large-diameter
myelinated A ﬁbers, followed by medium-diameter myelinated B
ﬁbers and then small-diameter unmyelinated C ﬁbers28. In vivo
we report that optogenetic stimulation of motor ﬁbers in the
vagus nerve results in a heart rate response that has a slower onset
than electrical stimulation of motor and sensory ﬁbers, likely due
to differential ﬁber recruitment45. Our ﬁndings suggest that non-
electrical techniques such as optogenetics are needed to char-
acterize neural control of cardiac physiology. Although there was
robust expression of ChR2-eYFP as conﬁrmed by immunohis-
tochemistry, we cannot rule out that incomplete expression or
optical capture affected our results. We also show that activation
of vagal afferents decreases heart rate by enhancing para-
sympathetic efferent outﬂow and reducing sympathetic efferent
outﬂow centrally, consistent with a prior study showing that
global activation of vagal afferents in Vglut2-ChR2 mice and
selective activation of Npy2r-ChR2 vagal afferents causes a pro-
found bradycardia57. In support of our functional data, anato-
mical tracing studies have previously shown that cardiac vagal
afferent neurons in the nodose/jugular ganglion complex project
to neurons in the nucleus tractus solitarii of the medulla58. These
neurons then project to the nucleus ambiguus and the DMV in
the medulla to modulate parasympathetic efferent outﬂow58 and
to the paraventricular nucleus of the hypothalamus to modulate
sympathetic efferent outﬂow59. Future studies aimed at identify-
ing cardiac-speciﬁc vagal efferent and afferent ﬁbers, similar to
those performed in the lungs57 and the gastrointestinal system60,
are needed to better understand vagal control of cardiac phy-
siology and to design next-generation VNS therapies.
Overall, our data highlight the complexity of cardiac neural
circuitry and demonstrate that a multi-technique approach is
needed to delineate circuit wiring. Understanding the neural
control of organ function in greater detail is critical as neuro-
modulation therapies are emerging as promising approaches to
treat a wide range of diseases. Tools such as optogenetics and
AAVs are already providing new scientiﬁc insights into the
structure and function of peripheral neural circuits57,60. A com-
bination of these approaches will help disentangle neural control
of autonomic physiology and enable a new era of targeted neu-
romodulation approaches.
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Methods
Animals. Animal experiments complied with all relevant ethical regulations and
were approved by the UCLA and California Institute of Technology Institutional
Animal Care and Use Committee. ChAT-IRES-Cre (028861)61, Ai32 (024109)62,
C57BL/6J (000664), and Ai14 (007914) mice63 were purchased from the Jackson
Laboratory. TH-IRES-Cre mice (254)64 were purchased from the European Mutant
Mouse Archive. ChAT-ChR2-eYFP and TH-ChR2-eYFP mice were created by
crossing Ai32 mice with ChAT-IRES-Cre or TH-IRES-Cre mice, respectively. TH-
tdTomato mice were created by crossing Ai14 mice with TH-IRES-Cre mice. All
animals were kept on a 12 h light/dark cycle with ad libitum access to food and
water. Data for all experiments were collected from male and female adult mice
(>8 weeks old).
Plasmids. Plasmids used for AAV production include pUCmini-iCAP-PHP.S
(Addgene, 103006), pAAV-CAG-DIO-mRuby2 (Addgene, 104058), pAAV-CAG-
DIO-mNeonGreen21, pAAV-CAG-DIO-mTurquoise2 (Addgene, 104059), pAAV-
ihSyn1-DIO-tTA (Addgene, 99121), pAAV-TRE-DIO-mRuby2 (Addgene, 99117),
pAAV-TRE-DIO-mNeonGreen21, pAAV-TRE-DIO-mTurquoise2 (Addgene,
99115), pAAV-TRE-DIO-tdTomato (Addgene, 99116), and pAAV-CAG-DIO-
eYFP (Addgene, 104052). pAAV-CAG-DIO-ChR2(H134R)-eYFP was generated
by replacing the Ef1a promoter in pAAV-Ef1a-DIO-ChR2(H134R)-eYFP (a gift
from Karl Deisseroth, Addgene, 20298) with the CAG promoter from pAAV-
CAG-mNeonGreen21. pAAV-CAG-DIO-tTA was generated by replacing the
ihSyn1 promoter in pAAV-ihSyn1-DIO-tTA with the CAG promoter from pAAV-
CAG-mNeonGreen. pAAV-TRE-DIO-tdTomato-f has a farnesylation sequence
attached by overhang PCR65. The pHelper plasmid was obtained from Agilent’s
AAV helper-free kit (Agilent, 240071). CAG, Cytomegalovirus early enhancer
element chicken β-actin promoter; DIO= double-ﬂoxed inverted open reading
frame.
Virus production and puriﬁcation. AAVs were generated by triple transient
transfection of HEK293T cells (ATTC, CRL-3216) using polyethylenimine (Poly-
sciences, 23966-2)67. Viral particles were harvested from the media at 72 h post-
transfection and from the cells and media at 120 h post-transfection. Virus from
the media was precipitated at 4 °C with 40% polyethylene glycol (Sigma-Aldrich,
89510)68 in 2.5 M NaCl and combined with cell pellets suspended at 37 °C in 500
mM NaCl, 40 mM Tris, 10 mM MgCl2, and 100 U ml−1 of salt-active nuclease
(ArcticZymes, 70910-202). Clariﬁed lysates were puriﬁed over iodixanol (Cosmo
Bio USA, OptiPrep, AXS-1114542) step gradients (15, 25, 40, and 60%)69. Puriﬁed
viruses were concentrated, washed in sterile phosphate buffered saline (PBS), sterile
ﬁltered, and titered using quantitative PCR70. A detailed protocol for AAV pro-
duction and puriﬁcation is available66.
Systemic delivery of viruses. Intravenous administration of AAV vectors was
performed by retro-orbital injection with a 31-gauge needle in 6–8 week old
mice66. Following injection, 1–2 drops of proparacaine (Akorn Pharmaceuticals,
17478-263-12) were applied to the cornea to provide local analgesia.
Langendorff-perfusion of heart and cardiac ganglion stimulation. Mice were
given heparin (100U, i.p.) to prevent blood clotting and euthanized with sodium
pentobarbital (150 mg kg−1, i.p.). Once all reﬂexes subsided and following a
midsternal incision, hearts were rapidly excised and Langendorff-perfused at 37 °C
modiﬁed Tyrode’s solution containing the following (in mM): 112 NaCl, 1.8 CaCl2,
5 KCl, 1.2 MgSO4, 1 KH2PO4, 25 NaHCO3, and 50 D-glucose at pH 7.4. The
solution was continuously bubbled with 95% O2 and 5% CO2. Flow rate was
adjusted to maintain a perfusion pressure of 60–80 mmHg. An optical ﬁber (400
µm core, Doric Lens) coupled to a diode-pumped solid-state laser light source (473
nm, 400 mW, Optic Engine) was positioned for focal illumination of the IPV-GP
under the guidance of a ﬂuorescent stereomicroscope (Leica, M205 FA) ﬁtted with
a 1x Plan-Apochromat. An octapolar electrophysiology catheter (1.1F, Transonic)
was inserted into the left atrium and ventricle via a small incision in the left atrium
and 2 platinum electrodes were positioned in the bath to obtain intracardiac
electrograms and a bath electrocardiogram, respectively. Intracardiac electrograms
and electrocardiogram were ampliﬁed with a differential alternating current
ampliﬁer (A-M Systems, Model 1700 and Grass, P511, respectively) and con-
tinuously acquired (AD Instruments, PowerLab 8/35). Dose response curves were
performed to evaluate the effects of altering light pulse power (at 10 Hz and 10 ms),
frequency (at 10 ms and 221 mW), and pulse width (at 10 Hz and 221 mW) on
heart rate and AV interval. At the end of the experiment, atropine (10 uM) was
administered into the perfusate and stimulation (10 Hz, 10 ms, and 221 mW) was
repeated. All stimulations were performed for 10 s with 5 min between stimulations
for heart rate to return to baseline values.
In vivo vagus nerve and paravertebral ganglia stimulation. Mice were anes-
thetized with isoﬂurane (induction at 3–5%, maintenance at 1–3% vol/vol, inha-
lation), intubated, and mechanically ventilated (CWE, SAR-830). Core body
temperature was measured and maintained at 37 °C. For VNS, a midline neck
incision was performed and the left and right cervical vagus nerves were exposed. A
laser-coupled optical ﬁber was positioned above and bipolar platinum hook
electrodes coupled to a constant current stimulator (Grass, PSIU6 and Model S88)
below the right vagus nerve for focal optical or electrical stimulation, respectively.
Irradiance and current were titrated to achieve a 10% decrease in heart rate with
both vagi intact at 10 Hz and 10 ms, which was deﬁned as threshold intensity.
Threshold intensity for optogenetic stimulation was 77 ± 6mW and for electrical
stimulation was 33 ± 13 µA. Frequency response curves were performed at
threshold intensity and 10 ms. All stimulations were performed for 5 s with 5 min
between stimulations for heart rate to return to baseline values. For paravertebral
ganglia stimulation, a right lateral thoracotomy was performed at the second
intercostal space and the paravertebral chain from the stellate to T2 ganglion was
exposed. A laser-coupled optical ﬁber was positioned for focal illumination above
the craniomedial RSG or right T2 ganglion. Dose response curves were performed
to evaluate the effect of altering RSG stimulation frequency (at 10 ms and 126 mW)
and pulse width (at 10 Hz and 126 mW) on heart rate. The effect of RSG versus
right T2 ganglion stimulation (10 Hz, 10 ms, and 126 mW) on heart rate was also
evaluated. At the end of the experiment, propranolol (2 mg kg−1, i.v.) was admi-
nistered via a femoral vein and craniomedial RSG stimulation (10 Hz, 10 ms, and
126 mW) was repeated. All stimulations were performed for 10 s with 5 min
between stimulations for heart rate to return to baseline values. For vagus nerve
and paravertebral ganglia stimulation experiments, a lead II electrocardiogram was
obtained by two needle electrodes inserted subcutaneously into the right forepaw
and the left hindpaw.
Electrophysiology data analysis. The heart rate was averaged over 0.5 s before
and during stimulation. A minimum of three beats were averaged before and
during stimulation for P wave duration.
CTB heart injections. Mice were given carprofen (5 mg kg−1, s.c.) and bupre-
norphine (0.05 mg kg−1, s.c.) 1 h before surgery. Animals were anesthetized with
isoﬂurane (induction at 5%, maintenance at 1–3%, inhalation), intubated, and
mechanically ventilated. Core body temperature was measured and maintained at
37 °C. The surgical incision site was cleaned 3 times with 10% povidone iodine and
70% ethanol in H2O (vol/vol). A left lateral thoracotomy was performed at the
fourth intercostal space, the pericardium opened, and the heart was exposed. Ten
microliters of CTB conjugated to Alexa Fluor 488 (0.1% in 0.01 M PBS (vol/vol),
ThermoFischer Scientiﬁc, C22841) was subepicardially injected in the heart with a
31-gauge needle. The surgical wounds were closed with 6–0 sutures. Buprenor-
phine (0.05 mg kg−1, s.c.) was administered once daily for up to 2 d after surgery.
Animals were sacriﬁced 6 d later for tissue harvest.
Transcardial perfusion. Mice were given heparin (100U, i.p.) to prevent blood
clotting and euthanized with sodium pentobarbital (150 mg kg−1, i.p.). Once all
reﬂexes subsided, a midsternal incision was made and animals were transcardially
perfused with 50 mL ice-cold 0.01M PBS containing 100U heparin followed by 50
mL freshly prepared, ice-cold 4% paraformaldehyde (PFA; EMS, RT 15714) in PBS.
Tissues were postﬁxed in 4% PFA overnight at 4 °C, washed, and stored in PBS
with 0.01% sodium azide. Langendorff-perfused hearts were immersion ﬁxed in 4%
PFA overnight at 4 °C at the end of the functional experiments
iDISCO heart clearing. Whole mouse hearts were stained and cleared using a
modiﬁed iDISCO protocol29. Fixed hearts were dehydrated with a graded methanol
series (20, 40, 60, and 80% methanol in H2O (vol/vol), each for 1 h at room
temperature), washed twice with 100% methanol for 1 h at room temperature, and
chilled at 4 °C. Hearts were then incubated in 66% dichloromethane/33% methanol
overnight at room temperature with agitation, washed twice in 100% methanol for
1 h at room temperature, and chilled to 4 °C. Next, hearts were bleached with 5%
H2O2 in methanol (vol/vol) overnight at 4 °C. After bleaching, hearts were rehy-
drated with a graded methanol series, followed by one wash with 0.01 M PBS and
two washes with 0.01 M PBS with 0.2% Triton X-100, each for 1 h at room tem-
perature. For staining, hearts were permeabilized with 0.01 M PBS with 0.2%
Triton X-100, 20% DMSO, and 0.3 M glycine and blocked with 0.01 M PBS with
0.2% Triton X-100, 10% DMSO, and 5% normal donkey serum (NDS), each for 2 d
at 37 °C with agitation. Hearts were incubated in primary antibody rabbit anti-
PGP9.5 (Abcam, ab108986, 1:200) diluted in 0.01M PBS with 0.2% Tween-20 and
10 mgml−1 heparin (PTwH) for 1 week at 37 °C with agitation. Hearts were then
washed several times in PTwH overnight at room temperature before secondary
antibody donkey anti-sheep Cy3 (Jackson ImmunoResearch, 713-165-003, 1:300)
incubation in PTwH for 1 week at 37 °C with agitation. Primary and secondary
antibodies were replenished half way through staining. Hearts were then washed
several times in PTwH overnight at room temperature. For clearing, stained hearts
were dehydrated with a graded methanol series and incubated in 66% dichlor-
omethane/33% methanol for 3 h at room temperature with agitation. Hearts were
then washed twice in 100% dichloromethane for 15 min at room temperature.
Hearts were stored and imaged in benzyl ether (Millipore Sigma, 108014
ALDRICH; refractive index: 1.55).
PACT heart clearing. Whole and half mouse hearts were cleared using the PACT
protocol30. Fixed hearts were incubated in 4% acrylamide (Bio-Rad, 161-0140) and
0% PFA (A4P0) (wt/vol) overnight at 4 °C with agitation. Hearts were vacuum
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degassed and bubbled with N2 for 10 min each and then polymerized in fresh
A4P0 solution with 0.25% VA-044 thermal initiator (Wako) (wt/vol) for 3 h at 37 °
C. Hearts were cleared with 8% sodium dodecyl sulfate (Sigma-Aldrich, L3771)-
PBS (wt/vol) at pH 8.5 for 5 d (whole hearts) or 52 h (half hearts) at room
temperature with agitation. Hearts were then washed several times in PBS over 2 d
at room temperature. Hearts were stored and imaged in a refractive imaging
matching solution (RIMS) (refractive index= 1.46)30,34.
Immunohistochemistry. For whole-mount staining, ﬁxed hearts and ganglia were
blocked in 0.01 M PBS with 10% NDS and 0.2% Triton X-100 PBS for 6 h at room
temperature with agitation. Tissues were then incubated in primary antibody
diluted in 0.01 M PBS with 0.2% Triton X-100 and 0.01% sodium azide for 3 nights
at room temperature with agitation. The following primary antibodies were used:
rabbit anti-PGP9.5 (Abcam, ab108986, 1:500), rabbit anti-HCN4 (Alomone Labs,
APC-052, 1:100), chicken anti-GFP (Aves, GFP-1020, 1:1000), sheep anti-TH
(Millipore Sigma, AB1542, 1:200), and goat anti-ChAT (Millipore Sigma, AB144P,
1:50). Tissues were washed several times in 0.01M PBS overnight before incubation
in secondary antibodies diluted in 0.01 M PBS with 0.2% Triton X-100 and 0.01%
sodium azide for 2 nights at room temperature with agitation. The following
secondary antibodies were used: donkey anti-rabbit Cy3 (Jackson ImmunoR-
esearch, 711-165-152, 1:400), donkey anti-chicken 647 (Jackson ImmunoResearch,
703-605-155, 1:400), donkey anti-sheep Cy3 (Jackson ImmunoResearch, 713-165-
003, 1:400), and donkey anti-goat Cy3 (Jackson ImmunoResearch, 705-165-003,
1:400). Tissues were washed several times in 0.01M PBS overnight before being
mounted on microscope slides in RIMS.
Fixed brains were cryopreserved in a 30% sucrose PBS solution for at least 48 h
at 4 °C. Brains were then embedded in OCT (Tissue-Tek), frozen on dry ice, and
stored in −80 °C until sectioning. For cryosectioning, 40 µm coronal sections were
cut using a cryostat microtome (Leica). Sections of the medulla containing the
DMV (Allen Mouse Brain Reference Atlas) were blocked in 0.01 M PBS with 10%
NDS and 0.2% Triton X-100 for 1 h at room temperature with agitation. Sections
were then incubated in primary antibody diluted in 0.01M PBS with 10% NDS,
0.2% Triton X-100, and 0.01% sodium azide for 1 night at room temperature with
agitation. The following primary antibodies were used: rabbit anti-ChAT (Millipore
Sigma, AB143, 1:200) and chicken anti-GFP (Aves Labs, 1:1000). Tissues were
washed several times in 0.01M PBS with 0.2% Triton X-100 before incubation with
secondary antibody diluted in 0.01 M PBS with 10% NDS, 0.2% Triton X-100, and
0.01% sodium azide for 2 h at room temperature with agitation. The following
secondary antibodies were used: donkey anti-rabbit Cy3 (Jackson
ImmunoResearch, 711-165-152, 1:1000) and donkey anti-chicken 647 (Jackson
ImmunoResearch, 703-605-155, 1:400). Tissues were washed several times in 0.01
M PBS with 0.2% Triton X-100 before being mounted on microscope slides in
Fluoromount-G (Thermo Fisher Scientiﬁc, 00-4958-02).
Imaging, image processing, and imaging data analysis. Images were acquired
on a confocal laser scanning microscope (Zeiss, LSM 880) ﬁtted with the following
objectives: Fluar 5×/0.25 M27 Plan-Apochromat, 10×/0.45 M27 (working distance
2.0 mm), Plan-Apochromat 25×/0.8 Imm Corr DIC M27 multi-immersion, and LD
C-Apochromat 40×/1.1W Korr. Cleared heart in Supplementary Video 3 was
imaged on a custom-built lightsheet ﬂuorescence microscope ﬁtted with a 10×/0.6
CLARITY objective (Olympus, XLPLN10XSVMP)31.
All image processing was performed using Zeiss Zen 2.1 v11, Adobe Photoshop
and Illustrator, NIH ImageJ, Bitplane Imaris 8.3, and custom Matlab scripts.
Computational tracing of nerve ﬁbers to establish global innervation patterns
was performed using a customized version of the open-source software neuTube71
to perform initial batch tracing of image tiles. The resulting tracings were stitched,
ﬁltered, and visualized using custom Matlab scripts. Tracing of cholinergic neurons
from a cardiac ganglion to the SA node was performed semi-automatically using
neuTube.
Quantiﬁcation of cell transduction in cardiac ganglia (Fig. 3b and
Supplementary Fig. 3e), stellate ganglia (Fig. 6c), and medulla sections
(Supplementary Fig. 3b) was performed by manual cell counting using NIH ImageJ
Cell Counter.
For the stellate ganglion heat maps in Figs. 5d, 3d locations of CTB-labeled cell
bodies in each stellate ganglion were marked using NIH ImageJ Cell Counter.
Maximum intensity projection images were manually annotated with 2D polygonal
regions of interest demarcating the extent of the stellate ganglion. Marked cell
bodies outside the stellate ganglion were excluded from subsequent analysis.
Landmark point locations were selected along the stellate ganglion boundary (e.g.,
ansa). One right and one left stellate ganglion image were selected to serve as
reference shapes (white dashed outline in Fig. 5d). To align the landmarks for each
sample with the selected reference sample, a non-rigid warping was estimated by
ﬁtting a 2D thin plate spline warp72 with a regularization parameter of 1e−6. The
density of labeled cell bodies was estimated by binning the x,y-image coordinates of
each marked cell into 50 × 50 µm bins and counting the number of cells falling in
each bin in order to compute the number of cells per square µm in projection.
These density maps from each individual sample were then warped using the thin
plate spline warp estimated from the spatial landmark correspondences to align
them all with the reference sample. Finally, the densities were averaged point-wise
across samples. One could, in principle, perform warping and density estimation in
3D. However, we observed little variation in the densities labeled of cells along the
optical z-axis, presumably due to the consistent orientation of samples on slides.
Statistics. Microsoft Excel 16.21.1 and GraphPad Prism 8.0.1 were used for data
analysis and graph generation. The animal group sizes were chosen based on
preliminary data that suggested a large effect size. Two animals in which optoge-
netic stimulation of the IPV-GP was attempted were excluded from data analysis
owing to failed Langendorff-perfusion of the heart. Sample sizes are indicated in
ﬁgure legends or text. In Fig. 3b, 153 ± 27 cardiac ganglion neurons were counted
per animal. In Fig. 6c, 291 ± 62 stellate ganglion neurons were counted per animal.
In Supplementary Fig. 3b and e, 65 ± 17 DMV neurons and 202 ± 31 cardiac
ganglion neurons were counted per animal, respectively. Data distribution was
assumed to be normal, but this was not formally tested. Data are presented as
mean+/− s.e.m. Comparisons for all pairs were conducted with a two-tailed
Student’s t-test. P < 0.05 was considered statistically signiﬁcant.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the ﬁndings of this study are available from the corresponding
authors upon reasonable request. Viral vectors and protocols are available through
Addgene or Beckman Institute for CLARITY, Optogenetics, and Vector Engineering
Research for technology development and broad dissemination: http://www.
beckmaninstitute.caltech.edu/clover.shtml.
Code availability
Nerve ﬁber visualization and analysis algorithms used in this study are available are
available at: https://www.ics.uci.edu/~fowlkes/SPARC/volume/.
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